JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

A1980 SNS-032 (BMS-387032)

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A1794 LY2835219

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,potent and selective

≥30.15 mg/mL
A8501 PHA-848125

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor,potent and ATP-competitive

≥23.05 mg/mL
A8565 Purvalanol B

1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/CDK2/CDK4 inhibitor

≥21.65 mg/mL
A8643 WHI-P180

Summary: EGFR/Janus Kinase 3 inhibitor

Soluble in DMSO
A3575 LY2835219 free base

Summary: CDK inhibitor

insoluble in H2O; ≥4.83 mg/mL
A3806 SCH900776 S-isomer

Summary: Checkpoint kinase(Chk)inhibitor

≥37.6 mg/mL
B6042 K03861

Summary: CDK2 inhibitor

≥50.2 mg/mL
B4754 LDC000067

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK9 inhibitor, novel and highly specific

insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
B7464 TMCB

Summary: CK2 and ERK8 inhibitor

<13.37 mg/mL